Hunting Hill Global Capital’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Hunting Hill Global Capital's PRTK Position: Q3 2023 in Review

Hunting Hill Global Capital sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 361,226 shares — an estimated $798K sold.

Hunting Hill Global Capital first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $798K in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

• Hunting Hill Global Capital reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
• Hunting Hill Global Capital sold 361,226 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $798K.
• Hunting Hill Global Capital first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
• Hunting Hill Global Capital's Paratek Pharmaceuticals, Inc. position peaked at $798K in Q2 2023.
• 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Hunting Hill Global Capital's 13F filing for Q3 2023, filed 14 Nov 2023.